Trinity Biotech plc (TRIB) Misses Q4 EPS by 2c

Trinity Biotech plc (NASDAQ: TRIB) reported Q4 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $26 million versus the consensus estimate of $27 million.

For earnings history and earnings-related data on Trinity Biotech plc (TRIB) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M